Atlas Trials

Shanghai Best-Link Bioscience, LLC

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanghai Best-Link Bioscience, LLC

RecordFirmDate
A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer (NCT07658183)Shanghai Best-Link Bioscience, LLC2026-07-20
A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer (NCT07550842)Shanghai Best-Link Bioscience, LLC2026-06-16
A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy (NCT07414927)Shanghai Best-Link Bioscience, LLC2026-03-27
A Study of Single Dose of BL0175 in Postmenopausal Women (NCT07366632)Shanghai Best-Link Bioscience, LLC2026-01-26
A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer (NCT06738966)Shanghai Best-Link Bioscience, LLC2025-03-10
A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours (NCT06247657)Shanghai Best-Link Bioscience, LLC2024-01-03
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors (NCT05886868)Shanghai Best-Link Bioscience, LLC2023-10-24

Track Shanghai Best-Link Bioscience, LLC automatically

Every clearance here is in the API, with alerts when new ones post.